Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Growth Metrics
Income Statement
Others
Ratios

Ligand Pharmaceuticals (LGNDZ) Cash from Investing Activities (2016 - 2025)

Ligand Pharmaceuticals (LGNDZ) has disclosed Cash from Investing Activities for 16 consecutive years, with -$18.1 million as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities rose 53.13% to -$18.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$377.3 million through Dec 2025, down 162.64% year-over-year, with the annual reading at -$377.3 million for FY2025, 162.64% down from the prior year.
  • Cash from Investing Activities hit -$18.1 million in Q4 2025 for Ligand Pharmaceuticals, up from -$353.4 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $113.9 million in Q1 2022 to a low of -$353.4 million in Q3 2025.
  • Historically, Cash from Investing Activities has averaged -$16.9 million across 5 years, with a median of -$8.8 million in 2022.
  • Biggest five-year swings in Cash from Investing Activities: plummeted 824.71% in 2024 and later soared 229.64% in 2025.
  • Year by year, Cash from Investing Activities stood at -$35.7 million in 2021, then skyrocketed by 79.6% to -$7.3 million in 2022, then crashed by 41.19% to -$10.3 million in 2023, then crashed by 275.56% to -$38.6 million in 2024, then soared by 53.13% to -$18.1 million in 2025.
  • Business Quant data shows Cash from Investing Activities for LGNDZ at -$18.1 million in Q4 2025, -$353.4 million in Q3 2025, and -$10.7 million in Q2 2025.